Align Technology stock fell 1.10 percent before October 28 results

Published on 10/04/2026 at 19:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Align Technology stock was last at USD 143.74 on October 2, 2026, while Q2 adjusted EPS reached USD 2.64. The next report is scheduled for October 28, 2026.

Börsenhändler im NASDAQ-Saal mit Medtech-Kurscharts auf Bildschirmen — Align Technology Inc. Börsen-Editorial NASDAQ Handelssaal mit steigenden Medtech-Aktienkursen und Händlern US0162551016, Illustration mit AI erstellt.

Align Technology (ISIN US0162551016) stock was last at USD 143.74 on the Nasdaq on October 2, 2026 at 4:00 p.m. ET, down 1.10 percent from the prior close. The company will report third quarter 2026 results on October 28, 2026, after the market close, according to Align Technology in a release dated October 1, 2026.

October 28 is the next checkpoint

The scheduled release will test whether Align can convert clear-aligner growth into broader operating progress after a mixed second quarter. The company plans to publish the figures at 4:00 p.m. ET and hold its conference call at 4:30 p.m. ET on October 28, 2026, according to Align Technology.

The Q2 2026 figures show the split clearly. Revenue rose 4.3 percent year over year to USD 1.06 billion, while non-GAAP EPS reached USD 2.64 against a USD 2.66 consensus estimate, according to FinDog on September 23, 2026.

Aligners grow as scanners weaken

Clear Aligner revenue increased 8.2 percent to USD 870.9 million in Q2 2026, supported by 691,800 cases. Systems and Services revenue declined 10.8 percent to USD 185.3 million, making the scanner business the key counterweight to aligner growth, according to FinDog.

For Q3 2026, management expects worldwide revenue of USD 1.00 billion to USD 1.02 billion. That range sits below the USD 1.06 billion generated in Q2, while Zacks reported that 2026 revenue growth guidance remained at 3 percent to 4 percent on September 5, 2026, alongside a 6 percent clear-aligner volume outlook, according to Zacks.

Consensus target stays above the stock

MarketBeat lists a Moderate Buy consensus from 15 brokerages, comprising eight Buy ratings, six Hold ratings and one Strong Buy rating. The average 12-month target is USD 206.36, which places the target 43.6 percent above the USD 143.74 last price, according to MarketBeat on September 11, 2026. The gap reflects a market view that depends on sustained aligner growth and a recovery in scanners and services.

Stock remains below its yearly high

Align Technology stock was last at USD 143.74 on the Nasdaq on October 2, 2026 at 4:00 p.m. ET. Its 52-week range was USD 124.91 to USD 200.44, and its market capitalization was USD 10.3 billion.